Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion - Wikidata - awgldk - TriplyDB

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

http://www.wikidata.org/entity/Q30366235

about

Interventions for the management of malignant pleural effusions: a network meta-analysis Thoracoscopy: medical versus surgical-in the management of pleural diseases Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions Mechanisms of pleurodesis Pleural procedural complications: prevention and management Patient evaluation for rapid pleurodesis of malignant pleural effusions Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion Combined ultrasound-guided cutting-needle biopsy and standard pleural biopsy for diagnosis of malignant pleural effusions Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.Advanced malignant lung disease: what the specialist can offer.Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial Indwelling pleural drain for mobile management of malignant pleural effusion-combining benefits of both methods.An update in the management of malignant pleural effusion.Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?Safety of indwelling pleural catheter use in patients undergoing chemotherapy: a five-year retrospective evaluation.From "awake" to "monitored anesthesia care" thoracic surgery: A 15 year evolution.Complications of indwelling pleural catheter use and their management.Pleurodesis: technique and indications.Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax.Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion Diagnosis and management of malignant pleural effusions.Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.Advances in the investigation and treatment of pleural effusions.Pleural controversy: close needle pleural biopsy or thoracoscopy-which first?Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.Intrapleural therapy.

P2860

Q24185776-74FE8579-4168-45FA-AE99-A2BF11F361B3 Q26774966-34B3F47B-88F1-4590-A9E4-7C40103AC11F Q26858948-99824BFB-89CB-4F6B-A095-C4C5B6E1894A Q27015057-772FAA92-3000-4197-B2CE-110D903B5832 Q28083331-C35B05FB-65EF-4209-8675-FB3656658213 Q28822235-0E87D8B0-6CE1-4201-AD01-289100B54A9B Q28830889-8ABBCAE8-A71B-4098-B59B-02EFC8338713 Q33167910-52F3BFD4-6526-4EED-A859-E3C2C2BAF53B Q33404538-9A42C252-45DD-4A75-A50F-9B798A761B28 Q33967871-9E01D733-0893-4FB3-B235-CDE78D8589B8 Q34089063-2218141C-2B00-4EF4-9160-B4D305FD54B7 Q34129663-E09EFF87-1EC6-47A8-89AD-95DD69A9EC91 Q34476701-AD62633F-C24C-4B6B-9514-3829987A08CD Q34505962-48D90C5E-7884-4877-9763-211F6F899DCB Q34589249-C4BDEF4E-8F2C-4EB7-9422-BCA1C7E33353 Q34608340-EC654079-03FC-4C86-A6D2-9FF63C90C0EF Q34663877-4CD99819-557D-4A23-80CA-921613B085B8 Q34691504-D4D76640-A1D3-4576-841E-76BCA3797063 Q34814259-9FBA362E-CC00-4D59-9F2A-4D4C301498FA Q34984497-E1E49723-5FD1-4656-AC24-79B4B849599B Q35245115-BB9E4D03-3CE2-4338-AAEB-DC46F2006933 Q35245982-31FC6A44-1C3B-42A9-954B-22CDCE1D21A3 Q35662158-00967C62-6DA2-48F9-9AA6-CED84960B3D0 Q35739564-BE272995-BA45-442E-B0FF-012D84AEFE70 Q35954440-0C508550-8F81-45EC-9998-A2E847676005 Q36439297-961A89A2-1B77-4A61-A751-EF41AD1EF8D1 Q36559536-366B94F4-873D-4225-968A-371A4DC95B15 Q36724768-1F2BA236-1801-4C04-9A86-C338C4894D98 Q36761699-BBE6308B-0330-44C2-9481-817C49F3CFEC Q36777607-BAE7B7C2-2B2B-4AFF-BD0D-ABEFF96ACF8A Q36907325-37294124-725D-4405-80D4-FA75B070BCB8 Q37058163-A310B80E-D7B3-45BB-B91A-F02EB7B9D08F Q37100965-262DEFD6-014B-4760-8A67-1901EDEC003D Q37204010-A446DFF3-35E0-414C-A2B4-2848F6D6B30D Q37301691-B29E9989-50C2-4F79-8D7F-217F49D8D215 Q37521040-112838C1-70BE-4F49-81B4-0542BC425758 Q37730006-E3B10454-8DD3-4E6B-BE5C-C47A571D7F18 Q37857359-6B4BEC67-6DDB-4476-B3CA-A172F28ABE25 Q37872322-871D7496-C9ED-4C95-BBFB-6C511523DC66 Q37889400-CE167BA2-F577-4C39-BA97-44C7B904149B

P2860

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

http://www.wikidata.org/entity/Q30366235

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Phase III intergroup study of ...... for malignant pleural effusion

@ast

Phase III intergroup study of ...... for malignant pleural effusion

@en

type

label

Phase III intergroup study of ...... for malignant pleural effusion

@ast

Phase III intergroup study of ...... for malignant pleural effusion

@en

prefLabel

Phase III intergroup study of ...... for malignant pleural effusion

@ast

Phase III intergroup study of ...... for malignant pleural effusion

@en

P1433

Q30366235-2C201866-E26A-417F-8E44-87164AFA9380

P1476

Q30366235-F05E5E98-5E8A-458C-95A4-813874A19EE6

P2093

Q30366235-08318189-1D49-49D0-B831-57EA0B2CFB3A

Q30366235-1EDF34E5-0893-487F-99F7-FB6F0EA29824

Q30366235-25CF9F2B-8195-42B4-B37E-D270F0E6F9ED

Q30366235-26A26068-E2BA-4434-9A34-14C3A835CF9B

Q30366235-2C4C9439-A782-40EF-BFDF-B220B0D4465A

Q30366235-30D7F850-499C-4768-9B94-105AAE8D240F

Q30366235-63756B08-0E7C-4560-9C39-D0DD6583B53B

Q30366235-769A891A-CC4B-4B7F-AB94-F8F4BA29532C

Q30366235-7D5714CC-6E0C-45C5-A41F-5CDA754D6FB0

Q30366235-81825663-E999-4CDE-8BC1-FB294CB84B46

P2860

Q30366235-0A5FB7C2-86CF-4729-935A-C59C90C1FC18

Q30366235-24D456C6-FA3F-49D1-94DC-7CD39AD20572

Q30366235-288F0A11-1588-4421-972D-31802A108ED0

Q30366235-39328E13-EEE0-4F3B-A11E-FAF8355C1C6A

Q30366235-3AD28D66-97DE-4ACA-BD10-8479D29B1164

Q30366235-4063C967-1A54-475E-B5A5-10643C1A12F8

Q30366235-454453EC-6466-456B-B6C5-0FFC7C628BB2

Q30366235-67756283-385F-48C2-9624-E153AF074660

Q30366235-681F0715-DCDA-4D66-BECC-E38F8FD8783A

Q30366235-838640B7-CDCA-423E-A42C-C69927FC322C

P304

Q30366235-46C10C02-BE09-4C96-8D51-D8EC4F7A7B82

P31

Q30366235-00491165-3B79-423C-87BE-E561B5C88750

P356

Q30366235-9D44E7E3-0183-4102-A2A2-FCB1C4607FE2

P407

Q30366235-603F93FB-70F8-49BC-8C1B-B921D6E9ECF5

P433

Q30366235-2DDC6F6B-0BF9-4AF6-82CD-DC29C12F7761

P478

Q30366235-7FAD314C-9171-4F9D-8ADE-88F9E921A8D7

P50

Q30366235-B1E44F8F-FEE1-4FEA-BAB4-C2DFE8059448

Q30366235-FB9EA651-5922-4FFC-9382-4C8242FDFD53

P577

Q30366235-2C039715-E77D-49C3-92AF-C50E359B8A90

P698

Q30366235-5F722E2B-0AEC-4085-9AC7-CC4945803833

P932

Q30366235-5AF5CD24-8403-4ECE-976D-5808FBE9D6F6

P356

CHEST.127.3.909

P1433

P1476

Phase III intergroup study of ...... for malignant pleural effusion

@en

P2093

Carolyn M Dresler

http://www.w3.org/2001/XMLSchema#string

Cooperative Groups Cancer and Leukemia Group B

http://www.w3.org/2001/XMLSchema#string

David M Jablons

http://www.w3.org/2001/XMLSchema#string

Ernest Scalzetti

http://www.w3.org/2001/XMLSchema#string

George B Haasler

http://www.w3.org/2001/XMLSchema#string

James E Herndon

http://www.w3.org/2001/XMLSchema#string

Jemi Olak

http://www.w3.org/2001/XMLSchema#string

Kemp H Kernstine

http://www.w3.org/2001/XMLSchema#string

Leslie Kohman

http://www.w3.org/2001/XMLSchema#string

North Central Cooperative Oncology Group

http://www.w3.org/2001/XMLSchema#string

P2860

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data.

Evaluation of respiratory effects in miners and millers exposed to talc free of asbestos and silica.

Respiratory failure following talc pleurodesis.

Thoracoscopy talc poudrage : a 15-year experience.

Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis.

Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients.

Talc pleurodesis for the treatment of pneumothorax and pleural effusion.

Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.

Pleurodesis using talc slurry.

P304

909-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.127.3.909

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

David J. Sugarbaker

Eastern Cooperative Oncology Group

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15764775

http://www.w3.org/2001/XMLSchema#string

P932

4644736

http://www.w3.org/2001/XMLSchema#string